MENU
TARA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protara Therapeutics (TARA) Ownership - Who owns Protara Therapeutics?
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases... Show more
Profile
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
144.86M
P/E Ratio
N/A
Total Cash
170.29M
Projected Growth
N/A
Total Debt
4.48M
Revenue
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
4.63
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TARA
Capitalization
145M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
170M
Total Cash/Share
4.63
Total Debt
4.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
167M
P/B Ratio
0.87
Cash Flow
N/A
Earnings
-2.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
35K
Current Ratio
15.71
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-48.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.25
Shares Held By Institutions
155M
Shares Outstanding - Current
36.8M
Total Liabilities
14.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-20.833
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com